Mounjaro or Ozempic: Which is Best for Weight Loss?

Posted on May 9, 2025 by Sally-Anne Turner

Weight loss has never been easy. As more clinical trials and studies continue to shed light on the science behind chronic obesity and weight health, we begin to understand why. It's not just about diet and exercise alone. The complexity of weight management involves intricate hormonal systems, metabolic processes, genetic predispositions, and psychological factors that can make losing weight feel like an uphill battle for many people. Traditional approaches focusing solely on calorie restriction and increased physical activity often fail to address the underlying biological mechanisms that regulate body weight, leaving countless individuals frustrated and discouraged despite their best efforts.

That is why the demand for effective weight loss solutions continues to grow exponentially around the world. So many people are using injectable medications for weight loss, more than you think. Injectable medications like Mounjaro (tirzepatide) and Ozempic (semaglutide) or Wegovy (semaglutide) as they are called, for weight loss have become household names in the weight loss revolution, with an estimated 500,000 people in UK taking weight loss injections. But how do we know which is best for weight loss? This question is increasingly important as more individuals seek medically supervised solutions to address chronic obesity and its associated health complications.

Both medications have shown impressive results in clinical trials, but understanding their differences is crucial for making an informed decision about your weight loss journey. That's why we've put together the basics – everything you need to know about Mounjaro and Ozempic/ Wegovy. The choice between these medications isn't simply about picking the one with the highest weight loss percentage in studies; it's about understanding which treatment aligns best with your individual health profile, lifestyle requirements, medical history, and long-term wellness goals. At Bodyline Clinic, we've supported thousands of patients through their weight loss journeys with both medications, and our experienced clinical team understands the nuances that make each treatment suitable for different individuals.

Understanding the Basics: How These Medications Work

Mounjaro and Ozempic, or Wegovy for weight loss, belong to the injectable medication classification that helps with weight loss, but they work slightly differently. To truly understand which medication might be more suitable for your weight loss journey, it's essential to grasp the fundamental mechanisms through which these treatments operate within your body. Both medications represent significant advances in pharmaceutical approaches to obesity management, but their distinct mechanisms of action can lead to different outcomes for different patients.

Mounjaro is unique because its mechanism of action, tirzepatide, targets two hormones - GLP-1 and GIP - which work together to create a synergistic effect in regulating appetite to promote weight loss. Here's a bit of science to explain how: Tirzepatide mimics the effects of hormones called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) in the body. These hormones are usually released after mealtimes and help regulate blood sugar levels, control appetite, and aid in insulin production. By mimicking both GLP-1 and GIP hormones, Mounjaro helps reduce calorie intake, ensuring you are in a calorie deficit which ultimately promotes weight loss.

The dual-action mechanism of Mounjaro represents a significant advancement in weight management pharmacology. GLP-1 receptors are found throughout the body, including in the brain, pancreas, and gastrointestinal tract. When activated, they slow gastric emptying, which means food stays in your stomach longer, creating a prolonged feeling of fullness. This receptor activation also works on the appetite centres in your brain, reducing those persistent thoughts about food that can derail weight loss efforts. Meanwhile, GIP receptors complement these effects by enhancing insulin secretion when blood glucose levels rise and may also influence how your body stores and utilises fat. The combination of these two mechanisms creates what researchers describe as a synergistic effect, where the combined impact exceeds what either hormone would achieve independently.

Dr Morgan Toerien is a weight, health, and clinical wellness practitioner at Bodyline Clinic who explains the dual-action benefit clearly:

"Think of it a little bit like trying to fill a paddling pool with one hose or trying to fill it with two hoses. If you've got two different hoses, your chances of getting it filled quicker are better. With tirzepatide, patients can hedge their bets in terms of whichever one of their hormones is more likely to be deficient or more likely to be resistant to, and one will be in the package.

"However, the two things together also have a synergistic effect. The effect is magnified, and not just a duplication. It isn't just that you've got two hormones, therefore, you're twice as likely to lose weight. You're likely to lose much more than twice as much."

Ozempic, on the other hand, works by mimicking just one hormone (GLP-1) to achieve weight loss. Ozempic is medication used in the treatment of type-2 diabetes whereas Wegovy is the same medication branded for weight loss. Both medicine brands are classified as semaglutide. Despite targeting only one hormonal pathway, semaglutide has proven remarkably effective for weight management. The medication was initially developed and approved for managing type 2 diabetes, but researchers observed significant weight loss in patients using the medication, leading to the development and approval of Wegovy specifically for weight management at a higher dose than Ozempic.

Semaglutide works by binding to GLP-1 receptors with high affinity, creating sustained activation that lasts throughout the week between injections. This extended action means you experience consistent appetite suppression rather than fluctuating hunger levels. The medication also influences reward pathways in the brain, potentially reducing cravings for high-calorie foods and decreasing the psychological drive to eat. Many patients report that the constant "food noise" – those persistent thoughts about eating – diminishes significantly when taking semaglutide, making it easier to stick to healthier eating patterns without feeling deprived.

Mounjaro and Ozempic are administered through weekly injections and work by helping you feel fuller for longer, reducing hunger, and slowing down digestion. Both medications come in pre-filled injection pens designed for self-administration, typically injected subcutaneously into the abdomen, thigh, or upper arm. The once-weekly dosing schedule makes these treatments more convenient than daily medications, and most patients find the injection process straightforward after initial guidance from healthcare professionals. At Bodyline Clinic, our nurses provide comprehensive training on proper injection technique during your initial consultation, ensuring you feel confident and comfortable with the process.

However, Mounjaro's dual-action approach often leads to more significant weight loss results in clinical studies. The additional GIP component appears to enhance the weight loss effects beyond what GLP-1 activation alone can achieve. This doesn't mean Mounjaro is automatically the better choice for everyone, but it does explain why clinical trial data shows higher average weight loss percentages with tirzepatide compared to semaglutide. The mechanism through which GIP contributes to weight loss is still being fully understood by researchers, but current evidence suggests it may improve insulin sensitivity, influence fat metabolism, and potentially reduce inflammation associated with obesity.

Who can take Mounjaro or Ozempic?

Mounjaro and Ozempic (Wegovy for weight loss) are only prescribed to individuals who have a body mass index (BMI) that qualifies them as obese (over 30) or overweight (over 27) with weight-related health problems. These are the strict guidelines from Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) for legal prescription. These eligibility criteria exist to ensure that these powerful medications are prescribed to individuals who will benefit most from medical intervention for weight management.

Weight-related health problems that may qualify someone with a BMI over 27 for treatment include type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea, cardiovascular disease, fatty liver disease, and polycystic ovary syndrome (PCOS). The presence of these conditions indicates that excess weight is already impacting health, making medical weight loss intervention particularly important. At Bodyline Clinic, our comprehensive assessment process evaluates not just your BMI, but your complete health profile to determine whether Mounjaro or Ozempic is appropriate for your individual circumstances.

However, meeting the BMI criteria doesn't automatically mean you're suitable for these medications. Certain medical conditions may make these treatments unsuitable or require special consideration. Individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use these medications. Those with severe gastrointestinal disease, including gastroparesis or inflammatory bowel disease, may need alternative approaches. Pregnant or breastfeeding women cannot use these medications, and women of childbearing age should use effective contraception during treatment and for a period after discontinuation.

Your medical history plays a crucial role in determining which medication is most appropriate. If you have a history of pancreatitis, your clinician will carefully weigh the risks and benefits before prescribing either medication. Those with diabetic retinopathy should be monitored closely, particularly when starting treatment, as rapid blood sugar improvements can sometimes temporarily worsen this condition. Kidney function is another important consideration, as both medications are processed through the kidneys, and dosing adjustments may be necessary for individuals with impaired renal function.

Age is generally not a barrier to treatment, though special considerations apply for older adults. At Bodyline Clinic, we've successfully treated patients across a wide age range, from young adults to individuals in their seventies and beyond. Our specialist programme for patients aged 70 and over provides additional clinical oversight to ensure treatment safety and effectiveness for older adults who may have multiple health conditions or take several medications.

Current medications must also be reviewed before starting either Mounjaro or Ozempic. These weight loss injections can interact with other diabetes medications, potentially causing blood sugar levels to drop too low. If you're taking insulin or sulfonylureas, dosage adjustments will likely be necessary when starting GLP-1 or GIP/GLP-1 therapy. Other medications that slow gastric emptying may have enhanced effects when combined with these weight loss treatments, requiring careful monitoring and potential dose modifications.

Comparing Weight Loss Results

Ozempic was the first injectable weight loss therapy to hit the headlines due to its impressive clinical trials. Dubbed the 'game changer' of weight loss medications, it certainly lived up to its name. Clinical trials showed semaglutide helped users lose up to 10% of their original body weight over a 72-week period. This truly was game changing and began a series of chain reactions revolutionising the world of medical weight loss. To put this in perspective, a 10% weight loss for someone weighing 100 kilograms means losing 10 kilograms, which can significantly improve health markers including blood pressure, cholesterol levels, blood sugar control, and reduce strain on joints.

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme provided robust evidence for semaglutide's effectiveness. In the STEP 1 trial, participants using semaglutide 2.4mg (the Wegovy dose) alongside lifestyle interventions lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. Even more impressively, more than half of participants achieved at least 15% weight loss, and nearly one-third achieved 20% or greater weight loss. These results represented a significant advancement over previous pharmaceutical weight loss options and demonstrated that medication could produce weight loss results approaching those seen with bariatric surgery.

However, not long after Mounjaro came onto the scene, and produced results so far never seen before. Users typically experienced far superior weight loss results than with its competitors leading it to be pronounced the 'King Kong' of medical weight loss. Many participants lost 15-20% of their body weight over the same period of 72 weeks. The SURMOUNT clinical trial programme demonstrated tirzepatide's remarkable efficacy, with the highest dose achieving average weight loss of 20.9% over 72 weeks in the SURMOUNT-1 trial.

Breaking down these results further reveals the magnitude of Mounjaro's effectiveness. In the SURMOUNT-1 study, 89% of participants achieved at least 5% weight loss, 83% achieved at least 10% weight loss, 69% achieved at least 15% weight loss, and an impressive 57% achieved 20% or greater weight loss. For comparison, in the semaglutide STEP trials, approximately 86% achieved 5% or more weight loss, 69% achieved 10% or more, and 50% achieved 15% or more. While both medications produce substantial weight loss, tirzepatide's dual mechanism appears to provide an additional edge for many patients.

It's important to remember, though, that individual results can vary significantly, based on each person, how they react to the medication, and how much work they choose to put into the weight loss journey. Remember, what works best for one person might not be best for another! Factors influencing individual outcomes include baseline weight, metabolic health, adherence to lifestyle modifications, genetic factors, gut microbiome composition, sleep quality, stress levels, and concurrent medications. Some patients respond exceptionally well to semaglutide and may not need to switch to tirzepatide, while others find tirzepatide provides better appetite control and more significant weight loss.

Real-world effectiveness data from clinical practice often shows somewhat different results than controlled clinical trials. At Bodyline Clinic, we've observed that patients who engage fully with our comprehensive weight loss programme – attending regular appointments, following nutritional guidance, increasing physical activity, and addressing behavioural factors – typically achieve results that meet or exceed clinical trial averages. Conversely, patients who view the medication as a standalone solution without making complementary lifestyle changes generally see more modest results. This underscores the importance of viewing these medications as tools within a broader weight management strategy rather than as complete solutions in themselves.

The timeline of weight loss also differs somewhat between the medications. Most patients notice appetite reduction within the first week of starting either medication, but visible weight loss typically becomes apparent within the first month. Weight loss tends to be most rapid during the initial three to six months of treatment, then continues at a slower pace. The dose escalation schedule – gradually increasing the medication dose over several weeks – helps minimise side effects while allowing the body to adjust. Both medications require this titration period, though the specific schedules differ slightly between Mounjaro and Wegovy.

Long-term weight maintenance after stopping these medications remains an important consideration. Clinical trials examining what happens when patients discontinue treatment have shown that significant weight regain is common, highlighting that these medications work on the biological systems that regulate body weight rather than permanently resetting metabolism. This doesn't mean you'll necessarily regain all lost weight, but it does suggest that many patients may benefit from long-term treatment or need robust strategies for maintaining weight loss after discontinuation. At Bodyline, we work with patients to develop sustainable habits during treatment that support long-term weight maintenance, whether they continue medication indefinitely or eventually transition off treatment.

Side Effects and Tolerability

Both medications have similar side effects. The most common side effects are gastrointestinal issues like nausea, vomiting, and diarrhoea. These symptoms typically improve over time as the body adjusts to the medication. Understanding what to expect and how to manage these effects can significantly improve your treatment experience and help you persist through the initial adjustment period when side effects are most likely to occur.

Mounjaro's side effects might be more pronounced initially due to its dual-action mechanism, but many patients find them manageable with proper medical supervision. The gastrointestinal effects occur because both GLP-1 and GIP slow gastric emptying, meaning food stays in your stomach longer. This is actually part of how the medications work to promote weight loss, but it can cause uncomfortable sensations, particularly when you first start treatment or increase your dose. Nausea is typically most noticeable during the first few days after injection and tends to diminish as the week progresses.

Practical strategies can significantly reduce the impact of gastrointestinal side effects. Eating smaller, more frequent meals rather than large portions helps prevent the overfull feeling that can trigger nausea. Avoiding high-fat, greasy, or heavily spiced foods during the first few days after your injection can also help, as these foods take longer to digest and may exacerbate symptoms. Staying well-hydrated is crucial, particularly if you experience vomiting or diarrhoea. Many patients find that ginger tea, peppermint, or other natural remedies help settle their stomach. At Bodyline Clinic, our nurses provide detailed guidance on managing side effects and are available between appointments if you have concerns or need additional support.

Beyond gastrointestinal effects, both medications can cause other side effects that patients should be aware of. Fatigue is relatively common, particularly in the first few weeks of treatment. This may be partly related to reduced calorie intake as your appetite decreases, so ensuring you're eating adequate nutrition despite reduced hunger is important. Headaches occur in some patients, usually mild and temporary. Dizziness can happen, particularly when standing up quickly, which may be related to changes in blood pressure or blood sugar levels. Injection site reactions – redness, itching, or mild discomfort at the injection site – are usually minor and resolve quickly.

More serious but less common side effects require immediate medical attention. Severe abdominal pain that doesn't resolve could indicate pancreatitis, a rare but serious complication. Changes in vision should be reported promptly, particularly for patients with diabetes who may be at risk for diabetic retinopathy. Symptoms of gallbladder problems – pain in the upper right abdomen, particularly after eating, along with nausea and vomiting – warrant medical evaluation. Rapid heartbeat or palpitations should be discussed with your healthcare provider. At Bodyline, we conduct thorough initial assessments to identify patients who may be at higher risk for complications and provide ongoing monitoring throughout treatment.

The risk of hypoglycaemia (low blood sugar) is generally low with these medications when used alone, as they work in a glucose-dependent manner. However, if you're taking other diabetes medications, particularly insulin or sulfonylureas, the risk increases. This is why medication adjustments are often necessary when starting GLP-1 or GIP/GLP-1 therapy. Symptoms of hypoglycaemia include shakiness, sweating, confusion, rapid heartbeat, and hunger. If you experience these symptoms, checking your blood sugar and treating appropriately is important. Our clinical team at Bodyline works closely with patients who have diabetes to adjust medications appropriately and prevent hypoglycaemic episodes.

Tolerability differs somewhat between individuals, and what one person finds manageable, another might find intolerable. Some patients sail through treatment with minimal side effects, while others struggle more significantly. This is where the gradual dose escalation becomes so important – starting with a low dose and slowly increasing allows your body to adjust and typically results in fewer and less severe side effects compared to starting at a higher dose. If side effects become problematic, your clinician may slow down the dose escalation schedule or maintain you at a lower dose for a longer period before increasing.

Which One Works Best?

If we base this decision on results alone, Mounjaro is clinically proven to be the most effective weight loss injection for producing the largest amount of weight loss. The clinical trial data consistently shows higher average weight loss percentages with tirzepatide compared to semaglutide, and the proportion of patients achieving significant weight loss milestones (15%, 20%, or more) is notably higher with Mounjaro. From a purely numerical standpoint, if maximum weight loss is the primary objective, Mounjaro appears to have an edge.

However, the best weight loss injection is not about its results in clinical trials, it's about what works for you. Everyone is different, and everyone requires a unique approach to losing weight as just with any medical treatment, there is no 'one-size-fits-all' approach. Several factors beyond average weight loss percentages should influence your decision about which medication is most appropriate for your circumstances.

Some people may not be able to use medical weight loss injections, others may find they have intolerable side effects, and those that do use them may not achieve the same amount of weight loss as others. Medical history, current medications, lifestyle factors, treatment goals, cost considerations, and personal preferences all play important roles in determining the optimal choice. For instance, if you have a history of gastrointestinal issues, you might tolerate one medication better than the other. If you're taking multiple medications for diabetes, one option might integrate more easily with your existing treatment regimen.

Cost and availability are practical considerations that can't be ignored. Medication pricing, insurance coverage, and supply availability may differ between Mounjaro and Wegovy in your area. At Bodyline Clinic, we provide transparent pricing information and can discuss the cost implications of different treatment options during your consultation. We also stay informed about medication availability and can advise on alternatives if supply issues arise with your preferred medication.

Starting with semaglutide and potentially switching to tirzepatide later is a reasonable approach for some patients. Because Wegovy has been available longer, there's more long-term data on its use, which some patients and clinicians find reassuring. Starting with semaglutide allows you to see how you respond to GLP-1 therapy, and if results plateau or are less than desired, switching to Mounjaro's dual mechanism might provide additional benefit. Conversely, some patients prefer to start with the medication showing the highest efficacy in trials, viewing Mounjaro as the first-line option and keeping semaglutide as an alternative if needed.

Individual response variability means that some patients actually lose more weight on semaglutide than the average person loses on tirzepatide, while others respond better to tirzepatide. Genetic factors, gut microbiome composition, baseline hormone levels, and other individual characteristics influence how you'll respond to these medications. This is why personalised medical assessment is so crucial – your clinician can consider your unique profile when recommending a treatment approach.

We said it at the beginning, weight loss isn't easy, it never has been. What matters is finding a solution that works for you. That doesn't happen with online questionnaires and 5-minute meetings with busy pharmacists, but it does happen with supportive and experienced weight health professionals who prioritise your wellbeing, to find the answer to helping you with safe, effective, and sustainable weight loss. At Bodyline Clinic, our experienced clinical team has supported over 100,000 patients through their weight loss journeys across our seven CQC-registered clinics in the Northwest of England and through our nationwide online consultation service.

The Importance of Professional Guidance and Clinical Support

Regardless of which medication you are prescribed, professional medical supervision is crucial for success. Without guidance and support from experienced weight health clinicians, there is no guarantee of sustainable success with medical weight loss. The medication provides a powerful tool for appetite control and weight reduction, but it's only one component of a comprehensive weight management strategy. Think of these medications as catalysts that make the difficult work of weight loss more achievable, rather than as complete solutions that work independently of your efforts.

These medications are not magic solutions; they are tools to be used to gain the habits and sustainable life changes to make chronic obesity a thing of the past. Without proper supported medical care, you can only go so far, and are at risk of weight regain when the time comes to come off those injectable weight loss medications. The biological changes these medications create – reduced appetite, slower gastric emptying, improved insulin sensitivity – are temporary effects that last only as long as you're taking the medication. The permanent changes that prevent weight regain come from the habits you build, the relationship with food you develop, the activity patterns you establish, and the behavioural strategies you learn during treatment.

Comprehensive clinical support encompasses multiple elements that work together to maximise your success. Initial assessment involves detailed medical history review, physical examination, blood tests to check for underlying health issues, and discussion of your weight loss goals and previous attempts. This thorough evaluation ensures the medication is safe for you and helps identify any factors that might impact your response to treatment. At Bodyline, we also assess for conditions that commonly coexist with obesity, such as sleep apnoea, fatty liver disease, or hormonal imbalances, ensuring these are addressed as part of your overall care.

Ongoing monitoring throughout treatment is essential for safety and effectiveness. Regular appointments allow your clinician to track your weight loss progress, monitor for side effects, adjust medication dosing as needed, and provide encouragement and accountability. Blood pressure checks, blood tests to monitor metabolic health, and assessment of how you're tolerating the medication help ensure treatment remains safe. If you have diabetes, regular monitoring of blood sugar levels and adjustment of other diabetes medications prevents complications like hypoglycaemia. Our nurses at Bodyline provide this ongoing support through in-person appointments at our clinic locations or via secure video consultations for patients across the UK.

Nutritional guidance is a critical component of successful weight loss with these medications. While the medications reduce appetite, making healthy food choices within your reduced calorie intake becomes even more important. You need adequate protein to preserve muscle mass during weight loss, sufficient vitamins and minerals despite eating less, and a balanced approach that's sustainable long-term. Our nutritional advice helps you understand portion sizes, make nutrient-dense food choices, plan meals that satisfy you despite reduced appetite, and develop a healthy relationship with food that will serve you well after treatment ends.

Physical activity recommendations are tailored to your current fitness level and medical conditions. Exercise provides numerous benefits beyond calorie burning – it preserves muscle mass during weight loss, improves cardiovascular health, enhances insulin sensitivity, boosts mood, and helps establish routines that support long-term weight maintenance. We help patients find activities they enjoy and can sustain, starting at an appropriate level and gradually increasing as fitness improves. For patients with joint problems or other limitations, we suggest low-impact activities that provide benefits without risking injury.

Behavioural support addresses the psychological and emotional aspects of weight management. Many people have complex relationships with food, using it for comfort, stress relief, or emotional regulation. Breaking these patterns requires more than appetite suppression – it requires developing new coping strategies, addressing underlying emotional issues, and building self-efficacy around weight management. Our team helps patients identify triggers for overeating, develop alternative responses to emotional distress, set realistic goals, and build confidence in their ability to maintain changes long-term.

Managing expectations is another important aspect of clinical support. While these medications are highly effective, weight loss isn't always linear – plateaus occur, some weeks show better results than others, and individual responses vary. Having a clinician who can explain what's normal, when to be concerned, and how to navigate challenges helps patients persist through difficult periods rather than becoming discouraged and giving up. We celebrate successes, troubleshoot obstacles, and adjust approaches when needed to keep patients moving toward their goals.

At Bodyline, we provide comprehensive clinical support throughout your weight loss journey, including regular check-ups, monitoring of side effects, and lifestyle guidance to maximise your results. Our approach recognises that successful weight loss requires addressing multiple factors simultaneously – the biological aspects through medication, the nutritional aspects through dietary guidance, the physical aspects through activity recommendations, and the psychological aspects through behavioural support. This integrated approach, delivered by experienced healthcare professionals who specialise in weight management, gives you the best possible chance of achieving and maintaining significant weight loss.

If you are considering Mounjaro or Ozempic, contact Bodyline Clinic today to learn more about their medically supervised weight loss programmes and how they can support you on your weight loss journey. Our team can answer your questions about which medication might be most suitable for your circumstances, explain what to expect during treatment, discuss costs and payment options, and help you take the first step toward better health. Call 0800 995 6036 or complete a contact form for a call back from one of our friendly team members who can book your initial consultation at one of our clinic locations in Birkenhead, Liverpool, Manchester, St Helens, Stockport, Stoke-on-Trent, or Warrington, or arrange an online video consultation if you're located elsewhere in the UK.

Book a consultation at Bodyline Clinic to discuss whether Mounjaro or Wegovy is the right weight loss solution for your individual needs. Our experienced clinicians will conduct a thorough assessment, answer all your questions, and develop a personalised treatment plan that addresses your unique circumstances and goals. Don't let another year pass struggling with weight management – take action today and discover how medically supervised weight loss treatment can transform your health and wellbeing.

Contact Bodyline today to find out more about our safe and effective weight loss programmes and range of treatment options.

Whether you're just beginning to explore medical weight loss options or you've been researching for some time, Bodyline Clinic is here to support you with expert clinical care, evidence-based treatments, and the personalised attention you deserve. With over 18 years of experience, CQC registration across all our clinics, and a team of dedicated healthcare professionals who specialise in weight management, we're proud to be one of the UK's leading providers of medically supervised weight loss programmes. Join the thousands of patients who have transformed their lives with Bodyline's support, and take the first step toward a healthier, happier you.